Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
Clinical trial NCT00414336 · COMPLETED
Trial details
- NCT number
- NCT00414336
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-15
- Primary completion
- 2006-12-15
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.